Formulation and evaluation of Cyclosporin A emulgel for ocular delivery

References

• Balasubramaniam J , Kant S , Pandit JK . (2003). In vitro and in vivo evaluation of the Gelrite gellan gum-based ocular delivery system for indomethacin. Acta Pharm 53:251–61
   PubMedGoogle Scholar
• Belin MW , Bouchard CS , Phillips TM . (1990). Update on topical cyclosporin A. Background, immunology, and pharmacology. Cornea 9:184–95
   PubMed Web of Science ®Google Scholar
• Benitez del Castillo JM , del Aguila C , Duran S , et al . (1994). Influence of topically applied cyclosporine A in olive oil on corneal epithelium permeability. Cornea 13:136–40
   PubMed Web of Science ®Google Scholar
• Bother H , Waaler T . (1990). Rheological characterization of tear substitutes. Drug Dev Ind Pharm 16:755–68
   Web of Science ®Google Scholar
• Chen Y , Lu Y , Zhong Y , et al . (2012). Ocular delivery of cyclosporine A based on glyceryl monooleate/poloxamer 407 liquid crystalline nanoparticles: preparation, characterization, in vitro corneal penetration and ocular irritation. J Drug Target 20:856–63
   PubMed Web of Science ®Google Scholar
• Costa P . (2001). An alternative method to the evaluation of similarity factor in dissolution testing. Int J Pharm 220:77–83
   PubMed Web of Science ®Google Scholar
• Diebold Y , Jarrin M , Saez V , et al . (2007). Ocular drug delivery by liposome-chitosan nanoparticle complexes (LCS-NP). Biomaterials 28:1553–64
   PubMed Web of Science ®Google Scholar
• Du S , Sun CM , Shen Y , et al . (2011). Study on ophthalmic emulsion-gel of Cyclosporine A. Pharm Clin Res 19:215–19
   Google Scholar
• Er Y , Barnes TJ , Fornasiero D , et al . (2009). The encapsulation and release of guanosine from PEGylated liposomes. J Liposome Res 19:29–36
   PubMed Web of Science ®Google Scholar
• Gupta V , Bansal P , Gupta A , et al . (2010). Formulation and evaluation of topical gel of diclofenac sodium using different polymers. Drug Invention Today 2:250–3
   Google Scholar
• Kishore AS , Surekha P , Murthy PB . (2009). Assessment of the dermal and ocular irritation potential of multi-walled carbon nanotubes by using in vitro and in vivo methods. Toxicol Lett 191:268–74
   PubMed Web of Science ®Google Scholar
• Krenzer KL , Zhang JZ , Coffey MJ , et al . (2012). Safety of repeated topical ocular administration of a polycarbophil-based formulation in several models of ocular surgery in rabbits. J Cataract Refract Surg 38:696–704
   PubMed Web of Science ®Google Scholar
• Kumar L , Verma R . (2011). In vitro evaluation of topical gel prepared using natural polymer. Int J Drug Deliv 2:58–63
   Google Scholar
• Lallemand F , Felt-Baeyens O , Besseghir K , et al . (2003). Cyclosporine A delivery to the eye: a pharmaceutical challenge. Eur J Pharm Biopharm 56:307–18
   PubMed Web of Science ®Google Scholar
• Marquardt D , Sucker H . (1998). Oil-in water-emulsion gels: determination and mathematical treatment of flow properties. Eur J Pharm Biopharm 46:115–24
   PubMed Web of Science ®Google Scholar
• Mohamed MI . (2004). Optimization of chlorphenesin emulgel formulation. AAPS Journal 6:e26--32
   PubMed Web of Science ®Google Scholar
• Mondon K , Zeisser-Labouèbe M , Gurny R , et al . (2011). Novel Cyclosporin A formulations using MPEG–hexyl-substituted polylactide micelles: a suitability study. Eur J Pharm Biopharm 77:56–65
   PubMed Web of Science ®Google Scholar
• Niazi SK . (2009). Stability testing of new drug substances and products. In: Niazi SK , ed. Handbook of pharmaceutical manufacturing formulations. (second ed.). : Informa Healthcare, 52–9
   Google Scholar
• Parrott EL . (1970). Pharmaceutical technology: fundamental pharmaceutics. : Burgess Publishing Company
   Google Scholar
• Perioli L , Pagano C , Mazzitelli S , et al . (2008). Rheological and functional characterization of new antiinflammatory delivery systems designed for buccal administration. Int J Pharm 356:19–28
   PubMed Web of Science ®Google Scholar
• Rodriguez-Aller M , Kaufmann B , Guillarme D , et al . (2012). In vivo characterisation of a novel water-soluble Cyclosporine A prodrug for the treatment of dry eye disease. Eur J Pharm Biopharm 80:544–52
   PubMed Web of Science ®Google Scholar
• Schreiber SL , Crabtree GR . (1992). The mechanism of action of cyclosporin A and FK506. Immunol Today 13:136–42
   PubMedGoogle Scholar
• Schumacher A , Nordheim A . (1992). Progress towards a molecular understanding of cyclosporin A-mediated immunosuppression. Clin Investig 70:773–9
   PubMedGoogle Scholar
• Shahin M , Hady SA , Hammad M , et al . (2011). Novel jojoba oil-based emulsion gel formulations for clotrimazole delivery. APS PharmSciTech 12:239–47
   PubMed Web of Science ®Google Scholar
• Steiger M. (2010). Topical emulsion-gel composition comprising diclofenac sodium. US Patent 7,732,489 B2
   Google Scholar
• Stevenson D , Tauber J , Reis BL . (2000). Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial. The Cyclosporin A Phase 2 Study Group. Ophthalmology 107:967–74
   PubMed Web of Science ®Google Scholar
• Van Haeringen NJ . (1981). Clinical biochemistry of tears. Surv Ophthalmol 26:84–96
   PubMed Web of Science ®Google Scholar
• Van Ooteghem MMM . (1993). Formulation of ophthalmic solutions and suspensions. Problems and advantages. In: Edman P , ed. Biopharmaceutics of ocular drug delivery. : CRC Press, 27–42
   Google Scholar
• Wei G , Xu H , Ding PT , et al . (2002). Thermosetting gels with modulated gelation temperature for ophthalmic use: the rheological and gamma scintigraphic studies. J Control Release 83:65–74
   PubMed Web of Science ®Google Scholar